In March 2025, the company announced new strategies to get a direct-to-consumer presenting of its Wegovy weight loss drug. The company established a fresh pharmacy, referred to as NovoCare, which would charge shoppers $499 monthly for entry to the drug, under fifty percent the expense of the drug by way of other pharmaceutical distribution networks